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Streszczenie
Pacjentka, 60 lat, od kilku lat leczona z powodu mięśniako-
mięsaka gładkokomórkowego (leiomyosarcoma), w różnych 
lokalizacjach, ze zdiagnozowanym guzem serca, została pod-
dana leczeniu operacyjnemu wycięcia guza lewej komory ser-
ca. Wczesny okres pooperacyjny był powikłany wystąpieniem 
zespołu małego rzutu oraz bradyarytmią wymagającą zasto-
sowania czasowej stymulacji zewnętrznej serca. W dalszym 
okresie leczenia szpitalnego ze względu na objawy niewydol-
ności serca włączono odpowiednią farmakoterapię, uzyskując 
wyrównanie stanu chorej (NYHA III). Ze względu na radykalny 
charakter zabiegu nie podejmowano uzupełniających metod 
leczenia. Okres leczenia ambulatoryjnego był niepowikłany, 
stan chorej stabilny, obserwowano stopniową poprawę wydol-
ności fizycznej (NYHA III – NYHA II). Obecnie okres obserwa-
cji odległej przekroczył 12 miesięcy, nie stwierdzono nowych 
ognisk wzrostu nowotworu na podstawie badań ECHO i tomo-
grafii komputerowej (TK). Chora prowadzi normalny tryb życia. 
Na podstawie prezentowanego przypadku omówiono aktual-
nie stosowane postępowanie w przypadku guzów serca.
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CASE REPORTS
Abstract
We present a case report of a 60-year-old woman with a long 
history of leiomyosarcoma in different locations. She was ad-
mitted to the clinic due to a left ventricular tumor diagnosed 
in ECHO examination. The patient was qualified for radical tu-
mor resection. The early postoperative period was complicated 
due to low cardiac output syndrome and bradyarrhythmia re-
quiring temporary cardiac pacing. Optimized pharmacologi-
cal therapy resulted in a gradual reduction of symptoms and 
a clinical improvement of congestive heart failure (NYHA III – 
NYHA II). Due to the radical nature of the surgery, the patient 
was not referred for supplementary treatment. The follow-up 
currently exceeds 12 months – no new metastases have been 
found. This case provides an example of how to diagnose and 
treat heart tumors.
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Introduction
Leiomyosarcoma is a rare neoplasm with prevalence es-
timated at approximately 1% [1]. The neoplastic process is 
asymptomatic until the tumor starts exerting pressure on the 
surrounding organs, impairing their function. The primary fo-
cus may develop in the uterus, while the most common loca-
tions of secondary tumors include the retroperitoneal space 
[2, 3]. Metastases in the area of the heart are not typical of 
leiomyosarcoma, but such cases have also been reported [4-
11]. Tumor resection remains the treatment of choice.
Case report
The patient was an obese woman, aged 61, with a long 
history of hypertension, treated with continuous positive 
airway pressure (CPAP) for obstructive sleep apnea. Her 
medical history included incidents of angioedema during 
attempts at antihypertensive treatment with angiotensin-
converting enzyme (ACE) inhibitors. From 2004, the patient 
was treated for leiomyosarcoma located primarily in the 
uterus. The patient underwent numerous surgical proce-
dures (extirpation of the uterus, removal of a tumor in the 
right lumbar area, removal of a tumor in the right thigh, 
removal of a tumor in the left arm). Surgical treatment was 
supplemented by radio- and chemotherapy. The patient 
was referred to the Cardiology Clinic after a cardiac tumor 
was revealed in follow-up echocardiography. The tumor 
with jagged edges (35 × 35 mm) filled the apical portion of 
the left ventricle.
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Cardiac diagnostics was conducted due to the gradually 
deteriorating exercise tolerance, even though the patient’s 
fatigability could have been attributed to her age, body 
type, inactive lifestyle, and long-term hypertension with left 
ventricular hypertrophy leading to diastolic heart failure. 
Regular cardiac function in physical examination (76/min), 
quiet systolic murmur in the apex and Erb’s point, no aus-
cultatory changes over the lung fields, trace of peripheral 
swelling, and normal blood pressure with the currently ap-
plied treatment were noted. After a cardiological consul-
tation, the patient was qualified for surgical treatment 
of the tumor in the left ventricle. Due to the fact that the 
echocardiographic image clearly corresponded to a meta-
static course of leiomyosarcoma, other methods of diag-
nostic imaging were not utilized (Fig. 1). The patient was 
operated on with cardiopulmonary bypass, under systemic 
hypothermia (28°C), using crystalloid cardioplegia. The left 
ventricle was opened on the anterior wall between the 
posterior interventricular artery and the diagonal branch. 
A large tumor (3 × 3 cm) was removed from the wall of 
the left ventricle with the coagulation of the cut edges. The 
left ventricle was closed using felt-supported sutures. Aor-
tic cross-clamping time during the procedure was 19 min-
utes, while cardiopulmonary bypass time was 45 minutes. 
The early postoperative period at the intensive care unit 
was extended due to low cardiac output syndrome (EF 26%), 
requiring the inclusion of catecholamines, and bradyar-
rhythmia, necessitating – temporary external cardiac pac-
ing. The patient was moved to the Cardiology Clinic on the 
15th postoperative day (Fig. 2 and 3). Physical examination 
revealed the following: wound healed by first intention, tach-
ycardia – 100/min, blood pressure – 135/85 mmHg, crackles 
at the base of both lungs, traces of lower leg swelling, lack 
of postcardiotomy syndrome in echocardiography. Signs of 
heart failure requiring the implementation of an appropri-
ate treatment were dominant during subsequent hospitali-
zation. Due to the presence of angioedema in the patient’s 
medical history, ACE-I (angiotensin-converting-enzyme in-
hibitor) treatment was not applied. A follow-up ECHO ex-
amination revealed a slight improvement in left ventricular 
ejection fraction (LVEF 30%).
The applied pharmacological treatment stabilized the 
patient (NYHA III); a six-minute walk test with exercise 
tolerance at the level of 280 m was conducted before dis-
charge. Due to the radical nature of the tumor resection, no 
supplementary methods of treatment were implemented. 
The period of outpatient treatment, including cardiac reha-
bilitation, was uneventful; the condition of the patient was 
stable, with a gradual improvement of physical performance 
(NYHA III – NYHA II). After 3 months, a follow-up echocar-
diographic examination showed a further improvement of 
left ventricular ejection fraction (LVEF 38%). Currently, the 
long-term follow-up exceeds 12 months; no new neoplas-
tic foci were found in ECHO and computed tomography; 
left ventricular ejection fraction remains stable (LVEF 40%). 
The good clinical condition of the patient enables her to 
conduct her daily activities at a level sufficient for her needs.
Fig. 1.  Left ventricular tumor. Transthoracic echocardiographic exa-
mination, apical four-chamber view. The tumor is marked with an 
arrow
Fig. 2.  Echocardiographic image taken on the 15th day after tumor 
resection, apical four-chamber view
Fig. 3.  Echocardiographic image taken on the 15th day after tumor 
resection, tissue Doppler imaging. High E/E’ ratio indicates incre-
ased left ventricular filling pressure
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Discussion
Primary cardiac tumors are rare; metastatic tumors are 
encountered more frequently. These tumors are benign in 
75% of cases and malignant in 25%. The most common 
benign cardiac tumors include myxoma (approximately half 
of all cases), papillary fibroelastoma, and lipoma (16% for 
each type). Sarcomas constitute the dominant group of ma-
lignant tumors (95%), the most common being angiosar-
coma (28%). It is important to emphasize that metastatic 
heart tumors are over 20 times more frequent than primary 
tumors and are found in 10-12% of patients with neoplastic 
diseases [12]. Heart metastasis occurs most frequently in 
the course of lung, breast, and kidney cancers as well as 
in the case of lymphomas and melanoma. The prevalence 
of leiomyosarcoma in the adult population is estimated 
at 5% of all cardiac tumors and 1% of all neoplasms. Sar-
comas develop from mesenchymal tissue, which explains 
their diversity. More than half of the patients are men aged 
between 50 and 60 years. Leiomyosarcoma, as opposed 
to angiosarcomas, is characterized by slow, asymptomatic 
growth. Leiomyosarcoma is most commonly localized in 
the retroperitoneal space (19%), but it may also develop in 
the uterus, stomach, intestines, skin, and vascular walls. 
Leiomyosarcoma of the heart is usually located in the left 
atrium, but it may also occur in the left ventricle, as in the 
case presented above. The tumors are usually situated on 
a wide, gelatinous base. It is assumed that some of them 
may develop from the smooth muscles of pulmonary veins. 
Due to their oligosymptomatic course, cardiac tumors are 
underdiagnosed; diagnosis is established intraoperatively 
or during an autopsy. The development of medical imaging 
methods enabled earlier diagnosis of cardiac tumors. Due 
to the slow and asymptomatic growth and lack of specific 
biochemical markers, the main role in diagnostics is played 
by imaging methods, mainly ultrasound [1]. In the case of 
cardiac tumors, transthoracic echocardiography is of pri-
mary importance for establishing a preliminary diagnosis. 
An echocardiographic diagnosis of a cardiac tumor requires 
differentiation; apart from tumors, it is necessary to con-
sider thrombi or bacterial vegetation. The final diagnosis is 
frequently reached through correct differentiation based on 
the patient’s disease history as well as tumor location and 
structure [13]. Other methods of medical imaging used in 
the diagnostics of cardiac tumors include transesophageal 
echocardiography and computed tomography. Magnetic 
resonance remains the reference imaging examination in 
the course of the diagnostic process [14]. The results of im-
aging examinations enable the assessment of the anatomi-
cal condition in the area of the tumor, which allows for the 
establishment of the extent of myocardial, pericardial, and 
extracardiac involvement [15].
Possible clinical symptoms: tumors in cardiac cavities 
usually cause heart failure with its typical symptomatology, 
while cardiac dysrhythmia may be expected in the case of 
intramural tumors. The clinical manifestation of cardiac tu-
mors is dependent on the influence of tumor location and 
size on the hemodynamics of the heart. Moreover, left heart 
tumors may cause embolisms in the systemic circulation, in 
the form of ischemic stroke, infarctions of abdominal or-
gans, and peripheral embolisms in extremities. In advanced 
forms of the disease, tumor growth is frequently accompa-
nied by the presence of bloody exudate in the pericardial 
sac, which may result in the development of life-threaten-
ing tamponade. The treatment of choice for cardiac tumors 
is tumor resection. The general operative indications for 
cardiac tumors result from the hemodynamic disorders as-
sociated with tumor growth, increased risk of embolism, 
and cardiac dysrhythmia. The main factors determining the 
results of cardiac surgical treatment include the general 
condition of the patient, the stage of the underlying neo-
plastic process (infiltration by continuity), and the occur-
rence of clinically significant distant metastases (crucial for 
prognosis). Therefore, surgical treatment is rarely applied, 
and long-term surgical treatment results are poor. In the 
case of the present patient, the ailments were associated 
with heart failure in NYHA class II; however, as a result of 
the irregular, jagged surface of the tumor revealed in echo-
cardiography, this form of the disease was characterized by 
increased risk of embolic complications. The condition of 
the patient, anatomy of the tumor, and lack of metastases 
to other organs at the current stage of the disease ena-
bled the qualification of the patient for surgical treatment. 
In the case of malignant tumors, a surgical procedure is 
not a fully effective method of treatment [16], but isolated 
cases of lasting recovery after radical tumor resection have 
been described in the literature [17]. The factors determin-
ing unfavorable prognosis include incomplete tumor resec-
tion and high grade of tumor differentiation (G3) leading to 
the rapid spread of metastases, mainly to the lungs and the 
brain [18]. The effectiveness of adjuvant radio- and chemo-
therapy in the treatment of leiomyosarcoma has not yet 
been explicitly established, while the applied therapeutic 
schemes were transferred from the treatment of soft tissue 
sarcomas.
In the present case, the occurrence of low cardiac out-
put syndrome, treated with a catecholamine infusion, and 
symptomatic bradyarrhythmia, requiring temporary ex-
ternal cardiac pacing, constituted significant problems in 
the early postoperative period. The complications were as-
sociated with the extent of the procedure, the necessary 
coagulation of the tumor resection line with subsequent 
necrosis of the adjacent tissue, and postoperative myocar-
dial stunning. The applied pharmacological treatment and 
cardiac rehabilitation enabled the reduction of heart failure 
symptoms to NYHA class II, with a gradual improvement of 
left ventricular ejection fraction. A standard management 
after cardiac tumor resection is yet to be established; the 
prognosis is not certain due to the risk of local recurrence, 
occurring in half of the patients undergoing surgery, as well 
as the appearance of metastases, observed in 20-40% of 
cases [19]. In cases of primary cardiac tumors and incom-
plete tumor resection, the average time of survival is esti-
mated at 6 to 12 months, while, in the case of radical tu-
mor resection, various reports estimate it at 24-45 months; 
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radical procedures may consist in autotransplantation with 
the reconstruction of the removed elements of the heart 
[20]. The majority of reports concerning cardiac surgery 
and adjuvant chemotherapy, however, estimate the aver-
age survival time at approximately 18 months. Sarcomas 
are characterized by the recurrence of hyperplasia, which 
necessitates regular clinical monitoring with diagnostic 
imaging methods (watchful waiting strategy). In the case 
of leiomyosarcoma, it is recommended to carefully con-
sider the possibility of local recurrence and metastasis to 
the brain and lungs. Currently, the long-term follow-up of 
the present patient exceeds 12 months. No new neoplas-
tic foci have been revealed by ECHO and CT examinations. 
The good clinical condition of the patient enables daily ac-
tivity at a level sufficient for her needs.
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